Evidence map›Paper›PMID 35548723›Full record

ArticleRSC advances2018

Coptisine suppresses tumor growth and progression by down-regulating MFG-E8 in colorectal cancer.

Qianyu Cao, Shengwei Hong, Yuanyuan Li, Heng Chen, Yining Shen, Kang Shao, Mengjie Lu, Hui Dai, Shitang Ma, Guoliang Dai

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Antitumor Alkaloids in Tibetan Corydalis: Chemical Diversity and Pharmacological Insights.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Current topics in medicinal chemistry · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Isoquinoline Alkaloids fromInternational journal of molecular sciences · 2022
    Article
  12. Review
  13. Article
  14. Frontiers in pharmacology · 2022
    Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Qianyu CaoThe First Clinical College, Nanjing University of Chinese Medicine Nanjing 210023 P. R. China.
Shengwei HongThe First Clinical College, Nanjing University of Chinese Medicine Nanjing 210023 P. R. China.ORCID https://orcid.org/0000-0002-6851-867X
Yuanyuan LiThe First Clinical College, Nanjing University of Chinese Medicine Nanjing 210023 P. R. China.
Heng ChenThe First Clinical College, Nanjing University of Chinese Medicine Nanjing 210023 P. R. China.
Yining ShenThe First Clinical College, Nanjing University of Chinese Medicine Nanjing 210023 P. R. China.
Kang ShaoThe First Clinical College, Nanjing University of Chinese Medicine Nanjing 210023 P. R. China.
Mengjie LuThe First Clinical College, Nanjing University of Chinese Medicine Nanjing 210023 P. R. China.
Hui DaiThe First Clinical College, Nanjing University of Chinese Medicine Nanjing 210023 P. R. China.
Shitang MaCollege of Life and Health Sciences, Anhui Science and Technology University Fengyang 233100 P. R. China mast@ahstu.edu.cn.
Guoliang DaiDepartment of Clinical Pharmacology, Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029 P. R. China daiguoliang2@qq.com.ORCID https://orcid.org/0000-0001-8319-9374
Nanjing University of Chinese Medicine · CNAnhui University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treating colorectal cancer (CRC) continues to be a clinical challenge. Coptisine, an alkaloid derived from

Identifiers

PMID35548723
PMCPMC9085504
OpenAlexW2889213610

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.